A new study suggests that younger adults and children would derive greater benefits from H5N1 vaccines, even if they are not ...
The recommendations were made following a meeting that included experts from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense.
"With today's action, the FDA does not anticipate any impact on timing or availability of vaccines for the American public," ...
Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian ...
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) had been scheduled to meet to discuss the strains ...
The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.
The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.
Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian ...
PHILADELPHIA- Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the ...
PHILADELPHIA— Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian influenza virus ...
To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...
To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback